- JAMA. 1994 Jun 15;271(23):1859-65 - PubMed
- Alcohol Alcohol. 2004 Jul-Aug;39(4):336-9 - PubMed
- Gastroenterology. 2004 Dec;127(6):1724-32 - PubMed
- Arch Intern Med. 2008 Mar 24;168(6):663-6 - PubMed
- Vox Sang. 1988;55(3):152-6 - PubMed
Clinicians are required to assess abnormal liver chemistries on a daily basis. The most common liver chemistries ordered are serum alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase and bilirubin. These tests should be termed liver chemistries or liver tests. Hepatocellular injury is defined as disproportionate elevation of AST and ALT levels compared with alkaline phosphatase levels. Cholestatic injury is defined as disproportionate elevation of alkaline phosphatase level as compared with AST and ALT levels. The majority of bilirubin circulates as unconjugated bilirubin and an elevated conjugated bilirubin implies hepatocellular disease or cholestasis. Multiple studies have demonstrated that the presence of an elevated ALT has been associated with increased liver-related mortality. A true healthy normal ALT level ranges from 29 to 33 IU/l for males, 19 to 25 IU/l for females and levels above this should be assessed. The degree of elevation of ALT and or AST in the clinical setting helps guide the evaluation. The evaluation of hepatocellular injury includes testing for viral hepatitis A, B, and C, assessment for nonalcoholic fatty liver disease and alcoholic liver disease, screening for hereditary hemochromatosis, autoimmune hepatitis, Wilson's disease, and alpha-1 antitrypsin deficiency. In addition, a history of prescribed and over-the-counter medicines should be sought. For the evaluation of an alkaline phosphatase elevation determined to be of hepatic origin, testing for primary biliary cholangitis and primary sclerosing cholangitis should be undertaken. Total bilirubin elevation can occur in either cholestatic or hepatocellular diseases. Elevated total serum bilirubin levels should be fractionated to direct and indirect bilirubin fractions and an elevated serum conjugated bilirubin implies hepatocellular disease or biliary obstruction in most settings. A liver biopsy may be considered when serologic testing and imaging fails to elucidate a diagnosis, to stage a condition, or when multiple diagnoses are possible.
Oh RC, Hustead TR, Ali SM, Pantsari MW. Oh RC, et al. Am Fam Physician. 2017 Dec 1;96(11):709-715. Am Fam Physician. 2017. PMID: 29431403
Iluz-Freundlich D, Zhang M, Uhanova J, Minuk GY. Iluz-Freundlich D, et al. Ann Hepatol. 2020 Mar-Apr;19(2):204-208. doi: 10.1016/j.aohep.2019.08.004. Epub 2019 Sep 20. Ann Hepatol. 2020. PMID: 31628070
Maier KP. Maier KP. Praxis (Bern 1994). 2005 Feb 2;94(5):139-43. doi: 10.1024/0369-8394.94.5.139. Praxis (Bern 1994). 2005. PMID: 15745378 Review. German.
Suciu A, Abenavoli L, Pellicano R, Luzza F, Dumitrascu DL. Suciu A, et al. Minerva Gastroenterol Dietol. 2020 Sep;66(3):246-251. doi: 10.23736/S1121-421X.20.02660-4. Epub 2020 Jan 28. Minerva Gastroenterol Dietol. 2020. PMID: 31994373
Herlong HF. Herlong HF. Hosp Pract (Off Ed). 1994 Nov 15;29(11):32-8. doi: 10.1080/21548331.1994.11443103. Hosp Pract (Off Ed). 1994. PMID: 7962234 Review.
Xu Y, Wang XS, Zhou XL, Lu WM, Tang XK, Jin Y, Ye JS. Xu Y, et al. World J Gastroenterol. 2024 Aug 28;30(32):3766-3782. doi: 10.3748/wjg.v30.i32.3766. World J Gastroenterol. 2024. PMID: 39221071 Free PMC article.
Nastasa V, Minea B, Pasca AS, Bostanaru-Iliescu AC, Stefan AE, Gologan D, Capota R, Foia LG, Mares M. Nastasa V, et al. Int J Mol Sci. 2024 Aug 9;25(16):8701. doi: 10.3390/ijms25168701. Int J Mol Sci. 2024. PMID: 39201385 Free PMC article.
Müller SL, Kaumanns A, Adam KM, Osthoff M, Dräger S. Müller SL, et al. Am J Case Rep. 2024 Aug 25;25:e944508. doi: 10.12659/AJCR.944508. Am J Case Rep. 2024. PMID: 39182163 Free PMC article.
Zhou X, Xu Y, Wang X, Lu W, Tang X, Jin Y, Ye J. Zhou X, et al. Front Pharmacol. 2024 Jul 31;15:1432683. doi: 10.3389/fphar.2024.1432683. eCollection 2024. Front Pharmacol. 2024. PMID: 39144628 Free PMC article.
Chen D, Xu W, Wen Y, Tan X, Liu J. Chen D, et al. Medicine (Baltimore). 2024 Aug 9;103(32):e39248. doi: 10.1097/MD.0000000000039248. Medicine (Baltimore). 2024. PMID: 39121258 Free PMC article.